Does PEXIDARTINIB Cause Product use issue? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Product use issue have been filed in association with PEXIDARTINIB (Turalio). This represents 6.4% of all adverse event reports for PEXIDARTINIB.
62
Reports of Product use issue with PEXIDARTINIB
6.4%
of all PEXIDARTINIB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Product use issue From PEXIDARTINIB?
Of the 62 reports, 1 (1.6%) resulted in death, 7 (11.3%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEXIDARTINIB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does PEXIDARTINIB Cause?
Fatigue (378)
Product dose omission issue (335)
Hair colour changes (327)
Nausea (213)
Pruritus (186)
Aspartate aminotransferase increased (134)
Rash (131)
Off label use (130)
Alanine aminotransferase increased (124)
Diarrhoea (106)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which PEXIDARTINIB Alternatives Have Lower Product use issue Risk?
PEXIDARTINIB vs PHENACETIN
PEXIDARTINIB vs PHENAZOPYRIDINE
PEXIDARTINIB vs PHENCYCLIDINE
PEXIDARTINIB vs PHENELZINE
PEXIDARTINIB vs PHENOBARBITAL